BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hernández-Conde M, Llop E, Fernández Carrillo C, Tormo B, Abad J, Rodriguez L, Perelló C, López Gomez M, Martínez-Porras JL, Fernández Puga N, Trapero-Marugan M, Fraga E, Ferre Aracil C, Calleja Panero JL. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(42): 6658-6668 [PMID: 33268953 DOI: 10.3748/wjg.v26.i42.6658]
URL: https://www.wjgnet.com/1948-5182/full/v26/i42/6658.htm
Number Citing Articles
1
Yuping Ding, Quanjun Deng, Mei Yang, Haiyan Niu, Zuoyu Wang, Shihai Xia. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and TreatmentDiabetes, Metabolic Syndrome and Obesity 2023; : 3303 doi: 10.2147/DMSO.S431251
2
Giada Sebastiani, Nathalie Paisible, Cecilia Costiniuk, Joseph Cox, Dana Kablawi, Marina B. Klein, Nadine Kronfli, Jean-Pierre Routy, Julian Falutz, Bertrand Lebouché, Giovanni Guaraldi. The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot StudyDiagnostics 2022; 12(11): 2590 doi: 10.3390/diagnostics12112590
3
Yongshuai Liu, Huijun Chang, Yunqing Zeng, Jinhou Li, Yueyue Li, Yong Chen, Tao Zhou, Yanjing Gao. Influence of subcutaneous adipose tissue index on prognosis in cirrhotic patients following endoscopic therapy: a retrospective cohort studyLipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-023-01996-9
4
Vasilios Kotsis, Fernando Martinez, Christina Trakatelli, Josep Redon. Impact of Obesity in Kidney DiseasesNutrients 2021; 13(12): 4482 doi: 10.3390/nu13124482
5
Deng-Hua He, Yong-Zhan Zhang, Liang Xu, Jia-Jia Pei, Ying Zhang, Zhong-Fang Yan. Relationship between metabolic associated fatty liver disease and body fat ratio, visceral fat area, and resting metabolic rate estimated by bioelectrical impedance analysisWorld Chinese Journal of Digestology 2023; 31(2): 56 doi: 10.11569/wcjd.v31.i2.56
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
6
Jian Yang, Chuan Wang Li, Jing Ru Zhang, Honglin Qiu, Xiu Li Guo, Wei Wang. Perirenal Fat Thickness is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes MellitusDiabetes, Metabolic Syndrome and Obesity 2023; : 1953 doi: 10.2147/DMSO.S415477
7
M. Hernández-Conde, J.L. Calleja. La enfermedad hepática metabólica: una nueva pandemia prevenibleRevista de Gastroenterología de México 2023; 88(3): 197 doi: 10.1016/j.rgmx.2022.04.002
8
M. Hernández-Conde, J.L. Calleja. Metabolic liver disease: A new preventable pandemicRevista de Gastroenterología de México (English Edition) 2023; 88(3): 197 doi: 10.1016/j.rgmxen.2022.04.003
9
Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Ou-Yang Huang, Rafael S. Rios, Kenneth I. Zheng, Sui-Dan Chen, Hong-Lei Ma, Giovanni Targher, Christopher D. Byrne, Xiao-Yan Pan, Ming-Hua Zheng. PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver DiseaseJournal of Clinical and Translational Hepatology 2022; 10(3): 439 doi: 10.14218/JCTH.2021.00286
10
Yasir Mohammed Khayyat. Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi ArabiaWorld Journal of Hepatology 2021; 13(12): 2150-2160 doi: 10.4254/wjh.v13.i12.2150
11
Ker Ming Seaw, Christiani Jeyakumar Henry, Xinyan Bi. Relationship between Non-Alcoholic Fatty Liver Disease and Visceral Fat Measured by Imaging-Based Body Composition Analysis: A Systematic ReviewLivers 2023; 3(3): 463 doi: 10.3390/livers3030033
12
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic InterplayLife 2024; 14(2): 272 doi: 10.3390/life14020272